Literature DB >> 29526638

Skeletal muscle cells actively shape (auto)immune responses.

Ali Maisam Afzali1, Thomas Müntefering2, Heinz Wiendl2, Sven G Meuth2, Tobias Ruck3.   

Abstract

Histopathological analyses of muscle specimens from myositis patients indicate that skeletal muscle cells play an active role in the interaction with immune cells. Research over the last few decades has shown that skeletal muscle cells exhibit immunobiological properties that perfectly define them as non-professional antigen presenting cells. They are able to present antigens via major histocompatibility complex molecules, exhibit costimulatory molecules and secrete soluble molecules that actively shape the immune response in an either pro- or anti-inflammatory manner. Skeletal muscle cells regulate both innate and adaptive immune responses and are essentially involved in the pathophysiological processes of idiopathic inflammatory myopathies. Understanding the role of skeletal muscle cells might help to identify new therapeutic targets for these devastating diseases. This review summarizes the immunobiological features of skeletal muscle cells, especially in the context of idiopathic inflammatory myopathies, and discusses shortcomings and limitations in skeletal muscle related research providing potential perspectives to overcome them in the future.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemokines; Cytokines; Immunobiology; Inflammatory myopathies; Myositis; T cell costimulatory molecules

Mesh:

Year:  2018        PMID: 29526638     DOI: 10.1016/j.autrev.2017.12.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  24 in total

1.  Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.

Authors:  Yuki Yamada; Yoshihisa Shimada; Yojiro Makino; Yujin Kudo; Sachio Maehara; Takafumi Yamada; Masaru Hagiwara; Masatoshi Kakihana; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-02       Impact factor: 4.322

2.  The Role of Glycosylation in Inflammatory Diseases.

Authors:  Inês Alves; Manuel M Vicente; Ana M Dias; Joana Gaifem; Cláudia Rodrigues; Ana Campar; Salomé S Pinho
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Enrichment of Newly Synthesized Proteins following treatment of C2C12 Myotubes with Endotoxin and Interferon-γ.

Authors:  Catherine S Coleman; Bruce A Stanley; Charles H Lang
Journal:  Inflammation       Date:  2022-01-14       Impact factor: 4.657

4.  Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome.

Authors:  Ilaria Trestini; Isabella Sperduti; Marco Sposito; Dzenete Kadrija; Alessandro Drudi; Alice Avancini; Daniela Tregnago; Luisa Carbognin; Chiara Bovo; Antonio Santo; Massimo Lanza; Mirko D'Onofrio; Giampaolo Tortora; Emilio Bria; Michele Milella; Sara Pilotto
Journal:  ESMO Open       Date:  2020-05

Review 5.  Glycans as Key Checkpoints of T Cell Activity and Function.

Authors:  Márcia S Pereira; Inês Alves; Manuel Vicente; Ana Campar; Mariana C Silva; Nuno A Padrão; Vanda Pinto; Ângela Fernandes; Ana M Dias; Salomé S Pinho
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

6.  The IRE1α Arm of UPR Regulates Muscle Cells Immune Characters by Restraining p38 MAPK Activation.

Authors:  RuiCai Gu; Tao Huang; JiangWei Xiao; ZhaoHong Liao; JunHua Li; HaiQiang Lan; Jun Ouyang; JiJie Hu; Hua Liao
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

7.  Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity.

Authors:  Yi-Yu Lin; Ian Belle; Maria Blasi; Min-Nung Huang; Anne F Buckley; Wes Rountree; Mary E Klotman; Andrea Cara; Donatella Negri
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-13       Impact factor: 6.698

8.  Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Lorena Arribas; Maria Plana; Miren Taberna; Maria Sospedra; Noelia Vilariño; Marc Oliva; Natalia Pallarés; Ana Regina González Tampán; Luis Miguel Del Rio; Ricard Mesia; Vickie Baracos
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

9.  Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.

Authors:  Alessio Cortellini; Lucilla Verna; Giampiero Porzio; Federico Bozzetti; Pierpaolo Palumbo; Carlo Masciocchi; Katia Cannita; Alessandro Parisi; Davide Brocco; Nicola Tinari; Corrado Ficorella
Journal:  Thorac Cancer       Date:  2019-01-02       Impact factor: 3.500

Review 10.  Skeletal muscle as potential central link between sarcopenia and immune senescence.

Authors:  Christopher Nelke; Rainer Dziewas; Jens Minnerup; Sven G Meuth; Tobias Ruck
Journal:  EBioMedicine       Date:  2019-10-26       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.